Volume 9 Supplement 2
Characterization of envelope function of transmitted viruses circulating in Mbeya, Tanzania, and its impact on disease progression
© Nofemela et al; licensee BioMed Central Ltd. 2012
Published: 13 September 2012
An understanding of the biological characteristics of transmitted viruses provides important insights into HIV pathogenesis and informs vaccine development. The aim of the study was to characterize env function of transmitted viruses and its role in disease progression.
Ten sequences were generated from single genome amplicons from 10 individuals at acute infection (range = 3 - 6 months post-infection) and the sequence representative of the consensus was cloned and functional env clones from subtypes C (n= 6), D (n =1) and recombinants CD (n = 2), AC (n = 1) were generated. Pseudovirions were generated, and entry efficiency in TZM-bl cells, tropism, dependency on CD4 and CCR5 using HEK 293 dual-inducible Affinofile cells, and sensitivity to entry inhibitors, was measured.
Half the envelope clones showed high levels of entry (52 -164% infection relative to Du151a, a reference env clone), and the remaining five had low entry efficiency (1- 18 %). We found an association between entry efficiency and viral load at 3 months (p = 0.0022) and 12 months postinfection (p = 0.0347). There was no significant correlation between entry efficiency and the IC50 of sCD4 (p = 0.5074), TAK779 (p = 0.4366) and enfurvitide (p= 0.5821), suggesting that the difference in entry efficiency was not due to CD4 and CCR5 binding, or membrane fusion. However, only 3/10 transmitted viruses from the group with high entry efficiency were able to infect cells with low of levels of CD4 and high levels of CCR5 receptors.
Transmitted viruses have a range of entry efficiency in TZM-bl cells (with high CD4 and CCR5 levels) with high entry efficiency associated with higher viral loads. When the expression of CD4 was lowered, only three viruses were able to enter target cells, suggesting that transmitted viruses most likely target cells with high CD4 levels.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.